Back to search
FDAFDA · Food and drugs·Recall number D-1200-2016

LIDOCAINE 2% (PF) IN NACL, 10ML Vials, MEDAUS PHARMACY

Published July 20, 2016 · Recall initiated: May 13, 2016

Summary

FDA records drug Class II recall D-1200-2016, published July 20, 2016 and initiated May 13, 2016. Recalling firm: Medaus, Inc.; Status: Terminated; Reported quantity: 147 mL in Vials; Lot: Lot #: 151203-48, BUD: 05/31/16; Lot #: 151204-9, BUD: 06/01/16; Lot #: 151218-20, BUD: 06/15/16; Lot #: 160125-23, BUD: 07/23/16; Lot #: 160125-24, BUD: 07/23/16; Lot #: 160125-25, BUD: 07/23/16; Lot #: 160127-6, BUD: 07/25/16; Lot #: 160302-76, BUD: 08/29/16; Lot #: 160302-77, BUD: 08/29/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Medaus, Inc.
Distributor
U.S. Nationwide, Japan, and New Zealand.
Lot
Lot #: 151203-48, BUD: 05/31/16; Lot #: 151204-9, BUD: 06/01/16; Lot #: 151218-20, BUD: 06/15/16; Lot #: 160125-23, BUD: 07/23/16; Lot #: 160125-24, BUD: 07/23/16; Lot #: 160125-25, BUD: 07/23/16; Lot #: 160127-6, BUD: 07/25/16; Lot #: 160302-76, BUD: 08/29/16; Lot #: 160302-77, BUD: 08/29/16
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was LIDOCAINE 2% (PF) IN NACL, 10ML Vials, MEDAUS PHARMACY recalled?

Yes. FDA published recall D-1200-2016 on July 20, 2016. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail